BIAF announces CHEST 2026 presentation
- October 15, 2026 press release
- Sponsors Learning Theater at CHEST 2026
- Discusses CyPath Lung for lung cancer risk stratification
BIAFW
bioAffinity Technologies, Inc. SEC filings
Every EDGAR filing for bioAffinity Technologies, Inc. (BIAFW), newest first, with AI summaries and stories.
- Ticker
- BIAFW
- CIK
- 1712762
- Sector
- Biotech and pharma
- Latest filing
- 4d
Filings
Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.
ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE bioAffinity Technologies announces data presentation
- Presenting data at CHEST 2026 on sputum-based tests for lung inflammation.
- Tests detect protein biomarkers including biologic drug targets for asthma and COPD.
ROUTINEPRER14AbioAffinity Technologies, Inc.BIAFWLIVE bioAffinity Technologies to hold special meeting
- Scheduled for [ ], 2026 at 8:00 a.m. Central Time
- Votes needed on 5 proposals including warrant exercises and share reduction
- Proxy materials available at www.proxyvote.com
ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE bioAffinity Technologies raises $4M
- Closed on Oct 9, 2026
- Raised $4M before fees
- Sold 116,545 shares at $6.122
ROUTINE424B5bioAffinity Technologies, Inc.BIAFWLIVE 2 structured-note prospectuses
Securities offering
Show all 2
- 424B5Securities offering
- 424B5Securities offering
ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE bioAffinity Technologies gets patent notice
- Japan Patent Office issued a Notice of Allowance
- Patent covers CyPath Lung test for lung cancer
- Company has 22 awarded patents and 36 pending applications
ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE bioAffinity Technologies reports 100% sales growth in Q3 2026
- CyPath Lung sales up over 100% in Q3 2026 vs. 2025
- Number of physician offices using CyPath Lung increased 89%
- Sales volume increased 48% year-over-year
ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINEPRE 14AbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE424B3bioAffinity Technologies, Inc.BIAFWLIVE ROUTINEEFFECTbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINES-3/AbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINES-3bioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE NOTABLE10-QbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE424B4bioAffinity Technologies, Inc.BIAFWLIVE ROUTINEEFFECTbioAffinity Technologies, Inc.BIAFWLIVE ROUTINES-1/AbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE NOTABLES-1bioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINES-8bioAffinity Technologies, Inc.BIAFWLIVE ROUTINE424B3bioAffinity Technologies, Inc.BIAFWLIVE ROUTINEEFFECTbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE NOTABLES-1bioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE ROUTINE8-KbioAffinity Technologies, Inc.BIAFWLIVE